1Contamination control
You produced beta-lactam drugs without providing adequate cleaning of work surfaces to prevent cross-contamination.
Inspection Record
Morton Drug Company dba Morton LTC — FDA 483 Findings
Inspectors Sandra A Hughes · Tenzin JangchupThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
2Aseptic processing and sterility assurance
Materials or supplies were not disinfected prior to entering the aseptic processing areas.
3Aseptic processing and sterility assurance
Media fills were not performed that closely simulate aseptic production operations incorporating.
About this record
Extracted automatically from the document US FDA published on 2019-04-30. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
